相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cyclooxygenase inhibitors: From pharmacology to clinical read-outs
Paola Patrignani et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2015)
Synthesis, biological evaluation and docking analysis of a new series of methylsulfonyl and sulfamoyl acetamides and ethyl acetates as potent COX-2 inhibitors
Sara Consalvi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
New insights into the use of currently available non-steroidal anti-inflammatory drugs
Kay Brune et al.
JOURNAL OF PAIN RESEARCH (2015)
Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors
Mariangela Biava et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Cyclooxygenase-2 inhibitor suppresses tumour progression of prostate cancer bone metastases in nude mice
Marta Garcia et al.
BJU INTERNATIONAL (2014)
Anti-tumor activity of non-steroidal anti-inflammatory drugs: Cyclooxygenase-independent targets
Jason L. Liggett et al.
CANCER LETTERS (2014)
PET radiotracer [18F]-P6 selectively targeting COX-1 as a novel biomarker in ovarian cancer: Preliminary investigation
Maria Grazia Perrone et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Prostanoid Receptor EP2 as a Therapeutic Target
Thota Ganesh
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Novel non-cyclooxygenase inhibitory derivatives of naproxen for colorectal cancer chemoprevention
Tarek Aboul-Fadl et al.
MEDICINAL CHEMISTRY RESEARCH (2014)
COX-2 Protects against Atherosclerosis Independently of Local Vascular Prostacyclin: Identification of COX-2 Associated Pathways Implicate Rgl1 and Lymphocyte Networks
Nicholas S. Kirkby et al.
PLOS ONE (2014)
Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasis
Guodong Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation
Daniel J. Hermanson et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
COX-2-derived endocannabinoid metabolites as novel inflammatory mediators
Mireille Alhouayek et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Targeting apoptosis pathways by Celecoxib in cancer
Verena Jendrossek
CANCER LETTERS (2013)
Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide
Christopher J. Fowler et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2013)
Induction but not inhibition of COX-2 confers human lung cancer cell apoptosis by celecoxib
Robert Ramer et al.
JOURNAL OF LIPID RESEARCH (2013)
Novel Analgesic/Anti-Inflammatory Agents: 1,5-Diarylpyrrole Nitrooxyalkyl Ethers and Related Compounds as Cyclooxygenase-2 Inhibiting Nitric Oxide Donors
Maurizio Anzini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Synthesis, Pharmacological Characterization, and Docking Analysis of a Novel Family of Diarylisoxazoles as Highly Selective Cyclooxygenase-1 (COX-1) Inhibitors
Paola Vitale et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
The novel anti-inflammatory agent VA694, endowed with both NO-releasing and COX2-selective inhibiting properties, exhibits NO-mediated positive effects on blood pressure, coronary flow and endothelium in an experimental model of hypertension and endothelial dysfunction
A. Martelli et al.
PHARMACOLOGICAL RESEARCH (2013)
NSAID Conjugates with Carnosine and Amino Acids
Sandhyamayee Sahu et al.
SYNTHESIS-STUTTGART (2013)
Nitroxide derivatives of non-steroidal anti-inflammatory drugs exert anti-inflammatory and superoxide dismutase scavenging properties in A459 cells
Wilmarie Flores-Santana et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
NO-NSAIDs. Part 3: Nitric Oxide-Releasing Prodrugs of Non-steroidal Anti-inflammatory Drugs
Namdev Borhade et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2012)
Diarylheterocycle Core Ring Features Effect in Selective COX-1 Inhibition
Maria Grazia Perrone et al.
CHEMMEDCHEM (2012)
Improving the solubility of a new class of antiinflammatory pharmacodynamic hybrids, that release nitric oxide and inhibit cycloxygenase-2 isoenzyme
Mariangela Biava et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Identification and Characterization of Carprofen as a Multitarget Fatty Acid Amide Hydrolase/Cyclooxygenase Inhibitor
Angelo D. Favia et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Pharmacological Inhibition of Microsomal Prostaglandin E Synthase-1 Suppresses Epidermal Growth Factor Receptor-Mediated Tumor Growth and Angiogenesis
Federica Finetti et al.
PLOS ONE (2012)
Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions
Oscar Sasso et al.
PHARMACOLOGICAL RESEARCH (2012)
Theranostics: Combining Imaging and Therapy
Sneha S. Kelkar et al.
BIOCONJUGATE CHEMISTRY (2011)
Endocannabinoid Oxygenation by Cyclooxygenases, Lipoxygenases, and Cytochromes P450: Cross-Talk between the Eicosanoid and Endocannabinoid Signaling Pathways
Carol A. Rouzer et al.
CHEMICAL REVIEWS (2011)
Cyclooxygenase-2 in oncogenesis
Maria Teresa Rizzo
CLINICA CHIMICA ACTA (2011)
Enlarging the NSAIDs Family: Ether, Ester and Acid Derivatives of the 1,5-Diarylpyrrole Scaffold as Novel Anti-Inflammatory and Analgesic Agents
M. Biava et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Synthesis and Structure-Activity Relationship Studies of Urea-Containing Pyrazoles as Dual Inhibitors of Cyclooxygenase-2 and Soluble Epoxide Hydrolase
Sung Hee Hwang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Novel Analgesic/Anti-Inflammatory Agents: Diarylpyrrole Acetic Esters Endowed with Nitric Oxide Releasing Properties
Mariangela Biava et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Effects of polyunsaturated fatty acid consumption in diabetic nephropathy
Haim Shapiro et al.
NATURE REVIEWS NEPHROLOGY (2011)
NSAID Use Selectively Increases the Risk of Non-Fatal Myocardial Infarction: A Systematic Review of Randomised Trials and Observational Studies
Luis Alberto Garcia Rodriguez et al.
PLOS ONE (2011)
Synthesis and evaluation of the anti-inflammatory properties of selenium-derivatives of celecoxib
Dhimant Desai et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2010)
Novel Ester and Acid Derivatives of the 1,5-Diarylpyrrole Scaffold as Anti-Inflammatory and Analgesic Agents. Synthesis and in Vitro and in Vivo Biological Evaluation
Mariangela Biava et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Metabolic profiling of murine plasma reveals an unexpected biomarker in rofecoxib-mediated cardiovascular events
Jun-Yan Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Long-Chain Omega-3 Polyunsaturated Fatty Acids May Be Beneficial for Reducing Obesity-A Review
Jonathan D. Buckley et al.
NUTRIENTS (2010)
Omega-3 Fatty Acids and Inflammatory Processes
Philip C. Calder
NUTRIENTS (2010)
Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential
Kate Petersen Shay et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2009)
The case for the development of novel analgesic agents targeting both fatty acid amide hydrolase and either cyclooxygenase or TRPV1
C. J. Fowler et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Pharmacodynamic Hybrids Coupling Established Cardiovascular Mechanisms of Action with Additional Nitric Oxide Releasing Properties
Alma Martelli et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Antioxidant properties of MitoTEMPOL and its hydroxylamine
Jan Trnka et al.
FREE RADICAL RESEARCH (2009)
Synergy between Enzyme Inhibitors of Fatty Acid Amide Hydrolase and Cyclooxygenase in Visceral Nociception
Pattipati S. Naidu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Anti-obesity effects of long-chain omega-3 polyunsaturated fatty acids
J. D. Buckley et al.
OBESITY REVIEWS (2009)
Synthesis, in vitro, and in vivo biological evaluation and molecular docking simulations of chiral alcohol and ether derivatives of the 1,5-diarylpyrrole scaffold as novel anti-inflammatory and analgesic agents
Mariangela Biava et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways
Bora Inceoglu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Lipoic Acid: A Novel Therapeutic Approach for Multiple Sclerosis and Other Chronic Inflammatory Diseases of the CNS
Sonemany Salinthone et al.
Endocrine Metabolic & Immune Disorders-Drug Targets (2008)
Review - Recent developments in nitric oxide donor drugs
M. R. Miller et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Cyclooxygenase-2 inhibitors. 1,5-diarylpyrrol-3-acetic esters with enhanced inhibitory activity toward cyclooxygenase-2 and improved cyclooxygenase-2/cyclooxygenase-1 selectivity
Mariangela Biava et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin
Sandra Holt et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
The chemistry and biology of nitroxide compounds
Benjamin P. Soule et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Action of epoxyeicosatrienoic acids on cellular function
Arthur A. Spector et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Cardiovascular risk and inhibition of cyclooxygenase - A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase
Patricia McGettigan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer
T Daikoku et al.
CANCER RESEARCH (2005)
Design, synthesis, and biological evaluation of 6-substituted-3-(4-methanesulfonylphenyl)-4-phenylpyran-2-ones: A novel class of diarylheterocyclic selective cyclooxygenase-2 inhibitors
PNP Rao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Kinetics and mechanism of hydroxyl radical and OH-adduct radical reactions with nitroxides and with their hydroxylamines
A Samuni et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2002)
Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer
AJ Dannenberg et al.
LANCET ONCOLOGY (2001)
4-[5-methyl-3-phenylisoxazol-4-yl]-benzenesulfonamide, valdecoxib: A potent and selective inhibitor of COX-2
JJ Talley et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
分享论文
